Balsells J, Charco R, Lazaro J L, Murio E, Vargas V, Allende E, Margarit C
Department of Surgery, Hospital General Universitari Vall d'Hebron, Universidad Autonoma de Barcelona, Spain.
Br J Surg. 1996 Jun;83(6):758-61. doi: 10.1002/bjs.1800830610.
Between 1987 and 1993, 53 hepatic resections for hepatocellular carcinoma (HCC) were performed in 51 patients with cirrhosis. Limited hepatic resection was performed in 66 per cent of patients. The postoperative mortality rate was 13 per cent. The tumours recurred in 27 patients (53 per cent), and the cumulative recurrence rate at 1 and 4 years was 41 and 89 per cent, respectively. Mean time to recurrence was 11.7 months and the most frequent site was the liver (21 patients). The only significant risk factor for recurrence was symptomatic tumours. The recurrence rate of HCC in patients with cirrhosis with surgical resection alone is high and actuarial survival at 4 years is very low. Other approaches to the treatment of HCC in patients with cirrhosis require consideration.
1987年至1993年间,对51例肝硬化患者实施了53例肝细胞癌(HCC)肝切除术。66%的患者接受了局限性肝切除术。术后死亡率为13%。27例患者(53%)出现肿瘤复发,1年和4年的累积复发率分别为41%和89%。复发的平均时间为11.7个月,最常见的部位是肝脏(21例患者)。复发的唯一显著危险因素是有症状的肿瘤。仅接受手术切除的肝硬化患者中HCC的复发率很高,4年的精算生存率很低。需要考虑对肝硬化患者HCC的其他治疗方法。